Skip to content

Chewing Gum on Postoperative Ileus in Children

The Impact of Chewing Gum on Postoperative Ileus in Children Who Undergo Abdominal Surgery: a Prospective, Randomized, Controlled Pilot Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03666377
Acronym
GUM_1
Enrollment
140
Registered
2018-09-11
Start date
2018-12-01
Completion date
2024-12-31
Last updated
2024-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Ileus, Flatus

Brief summary

Traditional postoperative care has been challenged recently to improve and speedup recovery (including the return of bowel function) such that patients can be discharged to home more quickly. This approach includes earlier mobilization of the patient, and introducing solid food sooner. Additionally, there is evidence in adults to suggest that sham feeding by chewing gum may also speed up bowel recovery so the patient may tolerate a solid diet earlier. The aim of this study is to determine if gum chewing can enhance bowel recovery in children who undergo abdominal surgery.

Detailed description

After intestinal surgery, many patients suffer from a postoperative ileus (POI). The cause is multifactorial and can be attributed to surgery itself, the lingering effect of the anesthetic, the use of narcotics and decreased mobility of the patient. An ileus can delay the time to full diet, thus lengthening the hospital stay of the patient - sometimes up to several weeks. There is evidence that early drinking/eating and increased mobility may accelerate the return of bowel function. Fast-tracking is well documented in the adult literature; protocols have been put in place to enhance GI tract recovery and thus decrease the morbidity of a prolonged hospital stay and ileus. Fast-tracking has been done in pediatric patients but not in a large RCT for abdominal surgery.

Interventions

OTHERGum chewing

1 piece of sugarless gum to be chewed three times daily for 1 hour each.

Sponsors

University of Manitoba
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

This study is a prospective randomized, controlled trial.

Eligibility

Sex/Gender
ALL
Age
4 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Children more than or equal to 4 years of age * Children who undergo abdominal surgery (both laparoscopic or open) * Children who have an expected postoperative length of stay more than 24 hours

Exclusion criteria

* Children who are less than 4 years of age * Children who are unable to chew gum/swallow (e.g. intubated, decreased level of consciousness, cognitive or physical disability) * Children or their parents are not willing to sign consent * Children or their parents are unable to follow directions regarding gum chewing, * Children who have a GI dysmotility disorder (e.g. chronic intestinal pseudo-obstruction)

Design outcomes

Primary

MeasureTime frameDescription
Composite outcome: first flatus, first bowel movement, first solid oral intake (any)From time of leaving the operating room (time zero) until the time of event (first bowel movement, first flatus, first oral intake) or date of death of any cause, whichever comes first, assessed up to 30 days, measured in hoursDocumented by nurse, patient or caregiver

Secondary

MeasureTime frameDescription
ReadmissionFrom day of discharge (time zero) until the time of event (day of readmission) or date of death of any cause, whichever comes first, assessed up to 30 days, measured in daysNeed for readmission within 30 days of discharge
Swallowing/aspiration of gumFrom day of entering the operating room (time zero) until the time of event (swallowing/aspiration of gum) or date of death of any cause, whichever comes first, assessed up to 30 days, measured as yes/noMeasured as yes/no
Allergic reaction/adverse reaction to gumFrom day of entering the operating room (time zero) until the time of event (allergic reaction/adverse reaction to gum) or date of death of any cause, whichever comes first, assessed up to 30 days, measured as yes/noMeasured as yes/no
Length of stayFrom day of entering the operating room (time zero) until the time of event (day of discharge) or date of death of any cause, whichever comes first, assessed up to 30 days, measured in daysFrom day admission to day of discharge
Need for prokinetic/anti-reflux medicationFrom time of leaving the operating room (time zero) until the time of event (ordering of prokinetic/anti-reflux medication) or date of death of any cause, whichever comes first, assessed up to 30days, measured in hoursMeasured as yes/no if need for additional medications to facilitate return of bowel function
Narcotic useFrom time of leaving the operating room (time zero) until the time of event (ordering of narcotic medication) or date of death of any cause, whichever comes first, assessed up to 30days, measured in hoursQuantity of narcotics consumed (mg/kg total)
Re-operationFrom day of entering the operating room (time zero) until the time of event (Re-operation) or date of death of any cause, whichever comes first, assessed up to 30 days, measured as yes/noMeasured as yes/no

Countries

Canada

Contacts

Primary ContactAnna Shawyer, MD, MSc
ashawyer@hsc.mb.ca204-787-2394

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026